Ischemia and Reperfusion Flashcards

1
Q

oxygen paradox

A
too much of a good thing: oxygen-derived free
radical formation (reactive oxygen species (ROS))
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Calcium paradox

A

Large influx of calcium into the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pH paradox

A

pH moves from acidic to normal – potentiates many of the changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Inflammation causes

A

neutrophil activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When Are Oxygen Free Radicals Generated?

A

Myocardial ischemia favors oxygen free radical generation
 Tissue stores of endogenous antioxidants
depleted during ischemia  superoxide dismutase
 catalase  glutathione  glutathione peroxidase
 Oxygen not available until reperfusion after clamp off
Greatest risk (i.e. greatest production) occurs when oxygen returned to myocardium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What Factors Determine The Amount of Oxygen Free Radicals Produced?

A

Severity of ischemic injury  Activation and recruitment of neutrophils
to myocardium
 Level of O2 in the cardioplegic solution
 Presence of endogenous scavengers and inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what Changes Are Caused By Oxygen Free Radicals?

A

Peroxidation of lipid components of myocellular membranes
 steal electrons from lipid membranes  Impairment of vascular endothelial function
 produces vasoactive & antiinflammatory autocoids autocoids: act like local hormones, act near site of synthesis, short acting
 Results:  postischemic dysfunction  dysrhythmias  morphologic injury  necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How Do Oxygen Free Radicals Cause Injury?

A

Induce opening of mitochondrial permeability transition pore
 Act as neutrophil chemoattractants  Mediate dysfunction of sarcoplasmic reticulum  Contribute to intracellular calcium overload  Damage cell membrane by lipid peroxidation  Induce enzyme denaturation  Cause direct oxidative damage to DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the Mitochondrial Permeability Transition Pore?

A

Nonselective channel (protein) of inner mitochondrial membrane
 When open increases permeability of molecules <1500 Daltons
 When open oxidative phosphorylation is uncoupled
 Results in ATP and cell death  Closed during ischemia / open during
 Opens in response to mitochondrial calcium overload, oxidative stress, restoration of physiologic pH, and ATP depletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How Can We “Attack” The Oxygen Free Radical Problem?

A

Administer pharmacological agents that inhibit the formation of oxygen free radicals
 Anesthetic agents, Anti arrhythmics may eliminate hydroxyl radicals, Vit C ->peroxides
 Administer pharmacological agents that scavenge / remove oxygen free radicals
 Mannitol, N-acetylcysteine, etc (page 182-183 Gravlee)
 Administer anti-neutrophil agents  Decrease ischemia-reperfusion injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What Changes Are Caused By Myocyte Calcium Influx?

A

Depletion of high-energy phosphate stores  Energy stores needed for ATP production
 Accumulation in mitochondria kills ability to produce ATP
 Inability to produce ATP affects:
 Ability of cell to contract
 Ability of cell to move calcium out of the cell or back into the SR
 Activation of catalytic enzymes  Increase cellular damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What Changes Are Caused By Myocyte Calcium Influx? 2

A

Alteration of excitation-contraction coupling of actin-myosin-troponin
 Calcium into the cell causes the contraction sequence
 Calcium not removed  Stone heart syndrome
 Calcium can enter by multiple pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What Starts The Activation of Neutrophils?

A

Receptor molecules will be activated / exposed  Start attachment process to the endothelium
 Three types of receptor molecules  selectins (P, L, E)
 Initial binding processes with endothelial wall
 beta2 integrins (CD11/CD18 complex)  Mediate firmer contact with wall
 immunoglobulin superfamily (ICAM-1)  Mediates final surface adherence
 Once bound – Diapedesis - blood goes thru capillaries
P-selectin (endothelial cells) triggered by proinflammatory mediators
 oxygen-derived free radicals  Hydrogen Peroxide etc
 thrombin  complement components  histamine
 Neutrophil recruitment triggered by similar proinflammatory mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neutrophil Products

A
hypoclorous acid
platelet activating factor
oxygen-derived free radicals
cytokines
 proteases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What Causes Myocardial Edema?

A

Increasedintracellularosmoticpressure  accumulation metabolic end-products of anaerobic glycolysis, lipolysis, ATP
hydrolysis
 Disruption of electrical potential across cell membrane  sodium / chloride accumulate inside the cell – attract water
 Increasedmicrovascularpermeability
 Increasedinterstitialosmoticpressure
 Highcardioplegiadeliverypressure
 Hypothermia induced changes to sodium-potassium pump
 Results  increasedmicrovasculatureresistance  increased diffusion distance to myofibril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How Can We Target The Perpetrators During Bypass?

A

Cardioplegia
 Ability to modify conditions of reperfusion and the composition of the solution
Conditions
hydrodynamics temperature route
Composition
pH metabolic substrate hypocalcemia oxygen pharmaceuticals

17
Q

How Do We Target The Perpetrators During Off-Pump Cases?

A

IV administration

 NO cardioplegia  NO hypothermia  MINIMAL cardiac work-load reduction

18
Q

What Clinical Results Do We See As a Result of RPI?

A

Dysrhythmias  PVC’s, fibrillation, non-spontaneous return of sinus rhythm,
dysrhythmia persistence  Systolic dysfunction
 contractile function / stroke volume  View by TEE or measure a Cardiac Output
 Diastolic dysfunction (compliance / relaxation)
 impaired filling

19
Q

What Clinical Results Do We See As a Result of RPI? 2

A

Myocardial necrosis  Endothelial dysfunction
 No reflow phenomenon
 Post ischemic tissue edema
 Interstitial hemorrhage
 Active vasoconstriction from loss of endothelium derived vasodilators
 Release of neutrophil derived vasoconstrictors  Capillary plugging by adhering neutrophils`

20
Q

When Can Myocardial Injury Occur?

A

Three phases

 Before bypass (think “lines”)  During cardioplegic arrest (think XC ON)  During reperfusion (think XC off)

21
Q

Phase One

A

Pre-bypass / before delivery of cardioplegia – “prebypass window”
 Period of unprotected ischemia
 coronary artery or other disease process
 hypotension due to dysrhythmia and/or cardiogenic shock
 coronary spasm

22
Q

Phase Two

A

 Cross-clamp applied / cardioplegia delivered  Period of protected ischemia
 unresolved coronary stenosis  obstruction within vascular graft (kink, tight anastomosis,
emboli)
 maldistribution of cardioplegia
 inadequate cardioplegia delivery (inadequate pressure or volume, inappropriate composition)
 between infusions of intermittent cardioplegia  unintentional interruption of continuous cardioplegia

23
Q

Phase Three

A

 Reperfusion


After cross-clamp removed
 earlyphase:<4hours
 late phase: 4 to 6 hours
 resolution of hypotension / dysrhythmia restores blood flow
 cardioplegia infused at high pressures or with improper composition
 coronary blood flow restored with unmodified blood after clamp removal
Ischemic injury also possible
 hypotension post clamp release (think “neo”)  during weaning/termination CPB (do not distend)  vascular graft thrombosis or mechanical obstruction  Dysrhythmias (watch EKG)  vasospasm of grafted vessel

24
Q

4 main objectives of cardioplegia

A

immediate/sustained electromechanical arrest
rapid/sustained homogenous myocardial cooling
maintenance of therapeutic additives in effective concentrations
periodic washout of metabolic inhibitors

25
Q

goals of myocardial protection

A

decrease oxygen demand
no activity to increase perfusion
minimize ischemia by controlling temperature and decompressing heart
control reperfusion by pharmological additives and target RPI perpetrators
off pump procedure?